Citi
-
Shenzhen-traded pharma firm prices Hong Kong IPO high -
-
-
First outing with new reference rate lands flat to just wide of fixed rate curve
-
-
Emerging markets bank one of just a handful of sizeable deals expected before 2022
-
Data centre Reit is tapping equity market to fund US, Canada acquisitions
-
Insurer hits Indian ECM with rare private sector deal
-
Public Investment Fund prices the deal at top of the range
-
Investors support the spin-off despite macroeconomic risks
-
-
International and local books were subscribed multiple times
